CHS/PFIZER CARE UNTIL CURE RESEARCH PROGRAM
In partnership with Pfizer, the CHS provides research grants to Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders, including hemophilia, people with von Willebrand disease or other inherited bleeding disorders, people with related conditions such as HIV or hepatitis C infection, and carriers of an inherited bleeding disorder.
Individual grants valued at $75,000 per year and per project will be awarded to researchers for a maximum of $150,000 which can be expended over 2 or 3 years.
Online application forms for the 2026-27 granting period, general criteria and specific areas of interest can be accessed at:
______________________________
CHS/NOVO NORDISK CANADA PSYCHOSOCIAL RESEARCH PROGRAM
In partnership with Novo Nordisk, the CHS provides research grants designed to engage professionals/graduate students from the allied health disciplines (i.e. nursing, physiotherapy and social work) in research activities with the goal of understanding the psychosocial impact of inherited bleeding disorders and to improve the quality of life of people and families whose lives are affected by these disorders. Multidisciplinary applications are welcomed.
Grants will be offered for one or two $20,000 research grants, to a maximum of $40,000 for one year. The major portion of the grant would be to cover the research time for the successful candidate(s), including the time for research assistants. A small amount can be devoted to project expenses. Grants will be offered for a one-year period to begin in April 2026.
Online application forms for the 2026-27 granting period and general criteria can be accessed at:
______________________________
THE CHS/BAYER/ADVANCE CANADA RESEARCH PROGRAM
In partnership with Bayer ADVANCE Canada, the CHS provides research grants focused on relevance to current practice in bleeding disorders care and incorporate a broad spectrum of quantitative and qualitative research methods addressing professional practice with individuals, families, groups and communities, organizational issues, public health, and education. The research should aim to provide better data and tools to help the treaters assist patients in successful ageing.
This research grant is geared towards a physician or Ph.D., or professionals from the allied health disciplines (i.e. nursing, physiotherapy and social work) with professional experience in a bleeding disorder treatment centre (BDTC) or other comparable settings in which care has been provided to people with inherited bleeding disorders. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. Collaboration with multidisciplinary care providers and/or between two or more treatment centres is accepted and encouraged.
One or two research grants will be offered for $22,500 to a maximum of $45,000 for one year.
Online application forms for the 2026-27 granting period, general criteria and further details can be accessed at: